14/7/2015

Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006: 3. Affordability and efficiency: 3.1 Therapeutic

Ayuda

Conctese / regstrese

English

Franais

Espaol

Portal de Informacin - Medicamentos Esenciales y Productos de Salud

Un recurso de la Organizacin Mundial de la Salud

Buscar

Buscar

Bsqueda avanzada

en
Documento completo | Captulo completo | Expandir ndice | Versin HTML imprimible

Temas & Palabras clave

Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006
(1998; 49 pages) [French] [Spanish]
ndice de contenido
Pgina inicial del Portal
Buscar

Acknowledgements
Executive summary

Ttulos A-Z
Temas

1. Introduction
2. Financing reforms

Palabras clave
Series y Peridicas
Publicadores
Autores A-Z
Regiones
Pases

3. Affordability and efficiency

3.1 Therapeutic efficiency in drug selection and use
3.2 Cost-control measures
3.3 Affordability for consumers
4. Organizational reforms
Conclusions

ndice

References

Subcolecciones

Back Cover

Public sub-collections

3.1 Therapeutic efficiency in drug selection and use

Therapeutic efficiency, which stems from the appropriate choice and use of drugs with proven safety and effectiveness, is key to
the achievement of pharmaceutical policy objectives and should lead to greater economic efficiencies in the health sector through
the elimination of waste. However the reverse is not necessarily true.
Changes in the health sector, including those associated with competition and economic incentives in the private sector, can lead
to improved flexibility and managerial efficiency, but may also provide economic incentives for irrational prescribing and drug use.
Any effort to improve the affordability, availability, and quality of drugs - be it in the public or private sector - should be
accompanied by sustained efforts to improve the rational use of drugs. These measures are varied and include, but are not limited
to, public and patient education, development of school curricula on rational use, and prescriber training.
Because the achievement of public health goals requires therapeutic efficiency, it is the responsibility of the government to ensure
that rational drug use is promoted regardless of the mechanisms selected for financing and providing drugs.

Mapa del sitio

Ayuda y servicios

Buscar
Ttulos A-Z
Temas
Palabras clave
Series y Peridicas
Publicadores
Autores A-Z
Regiones
Pases
ndice
Subcolecciones
Public sub-collections

Contactos
Preguntas frecuentes
Empleo
Sugerencias
Privacidad
Mensajes fraudulentos

Oficinas regionales de la
OMS
Pgina inicial de la OMS
Sistemas y Servicios de
Salud, OMS
Medicamentos, OMS
Sitios OMS

Conectar con la OMS

RSS
Youtube
Twitter
Facebook

OMS 2015
El Portal de Informacin - Medicamentos Esenciales y Productos de Salud de la OMS fue diseado y es mantenido por la ONG Human Info. ltima actualizacin: le 16 junio 2015

http://apps.who.int/medicinedocs/es/d/Jwhozip33e/5.html

1/1